|
Age at Parathyroidectomy
|
|
Age (years)
|
51.7 (13.1)
|
51.8 (13.0)
|
50.4 (13.9)
|
|
Dialysis Vintage (years)
|
7.0 (3.9)
|
7.1 (3.9)
|
5.3 (3.4)
|
|
Sex and Race Categories
|
|
Male (%)
|
1,487 (49.4%)
|
1,395 (50.7%)
|
92 (35.5%)
|
|
White (%)
|
1,173 (39.0%)
|
1,048 (38.1%)
|
125 (48.3%)
|
|
Black (%)
|
1,687 (56.1%)
|
1,567 (57.0%)
|
120 (46.3%)
|
|
Asian (%)
|
73 (2.4%)
|
NR
|
NR
|
|
Other (%)
|
75 (2.5%)
|
NR
|
NR
|
|
Cause of ESKD
|
|
Hypertension (%)
|
1,116 (37.1%)
|
1,007 (36.6%)
|
109 (42.1%)
|
|
Diabetes (%)
|
822 (27.3%)
|
789 (28.7%)
|
33 (12.7%)
|
|
Glomerulonephritis (%)
|
525 (17.5%)
|
467 (17.0%)
|
58 (22.4%)
|
|
Cystic kidney (%)
|
172 (5.7%)
|
NR
|
NR
|
|
Other (%)
|
75 (2.5%)
|
NR
|
NR
|
|
Year of Parathyroidectomy
|
|
2016 (%)
|
1,594 (53.0%)
|
1,462 (53.2%)
|
132 (51.0%)
|
|
2017 (%)
|
1,414 (47.0%)
|
1,287 (46.8%)
|
127 (49.0%)
|
|
Other Baseline Variables
|
|
Hospitalization in Prior 12 Months (%)
|
1,431 (47.6%)
|
1,361 (49.5%)
|
70 (27.0%)
|
|
Serum Calcium (corrected, mg/dL)
|
9.4 (0.8)
|
9.4 (0.8)
|
9.6 (0.9)
|
|
Serum Phosphate (mg/dL)
|
6.4 (1.6)
|
6.4 (1.6)
|
6.5 (1.7)
|
|
Calcimimetic Use Within 90 Days (%)
|
1,288 (42.8%)
|
1,205 (43.8%)
|
83 (32.0%)
|
|
IV Vitamin D Use Within 90 Days (%)
|
1,407 (46.8%)
|
NR
|
NR
|
|
Phosphate binder Use Within 90 Days (%)
|
1,417 (47.1%)
|
1,312 (47.7%)
|
105 (40.5%)
|
|
Charlson Comorbidity Index
|
|
CCI Index (continuous)
|
3.6 (3.4)
|
3.7 (3.4)
|
1.9 (2.5)
|
|
CCI Score 0 (%)
|
504 (16.8%)
|
405 (14.7%)
|
99 (38.2%)
|
|
CCI Myocardial Infarction (%)
|
450 (15.0%)
|
432 (15.7%)
|
18 (6.9%)
|
|
CCI Congestive Heart Failure (%)
|
1,279 (42.5%)
|
1,231 (44.8%)
|
48 (18.5%)
|
|
CCI Peripheral Vascular Disease (%)
|
840 (27.9%)
|
820 (29.8%)
|
20 (7.7%)
|
|
CCI Cerebrovascular Disease (%)
|
361 (12.0%)
|
341 (12.4%)
|
20 (7.7%)
|
